Tramadol HCl
Sponsors
Hadassah Medical Organization, Pfizer's Upjohn has merged with Mylan to form Viatris Inc., Labopharm Inc., Janssen Scientific Affairs, LLC, Bozyaka Training and Research Hospital
Conditions
BioavailabilityHealthyHealthy SubjectsInguinal HerniaLow Back PainPharmacokineticsPostoperative PainRenal Calculus
Phase 1
Study of Two Tramadol Contramid® OAD 300 mg Controlled-Release Tablets From Two Different Manufacturing Sites Following a 300 mg Dose in Healthy Subjects Under Fasting and Fed Conditions
CompletedNCT00834912
Start: 2006-02-28End: 2006-04-30Updated: 2012-04-30
A Study to Compare the Relative Bioavailability of Two 200 Mg Tramadol Hydrochloride Tablet Products Under Fasting Conditions
CompletedNCT00834366
Start: 2005-02-28End: 2005-03-31Updated: 2012-04-30
A Study to Compare the Bioavailability of Two Tramadol Hydrochloride Tablet Products (50 mg and 200 mg, Respectively) at Steady-state Under Fasting Conditions
CompletedNCT00834288
Start: 2003-06-30Updated: 2012-04-27
A Dose Linearity Study of the Labopharm Formulation of Tramadol HCl/Contramid®, 100 mg, 200 mg and 300 mg After A Single Oral Administration In Fasting Condition, In Healthy Human Volunteers
CompletedNCT00834808
Start: 2002-11-30End: 2002-12-31Updated: 2012-04-27
Study to Evaluate the Effects of Tramadol Hydrochloride on Cardiac Repolarization in Healthy Participants
CompletedNCT02307864
Start: 2014-12-04End: 2015-08-27Updated: 2018-08-29